CNTF and obesity disorder: In recent years, gp130 receptor ligands, including ciliary neurotrophic factor (CNTF) and interleukin (IL)-6, have been shown to modulate energy balance and investigated as potential therapeutic targets for obesity and insulin resistance [1].